Chronic lymphocytic leukaemia (CLL) 

UCLH is considered a centre of excellence in the management of patients with acute and chronic leukaemia. We provide an advanced diagnostic service and a comprehensive treatment programme for patients with different types of leukaemia. Our chronic lymphocytic leukaemia (CLL) service cares for patients who may only require monitoring, as well as for those who require treatment, whether this is first line treatment or those with relapsed CLL.

We have close academic links with University College London (UCL) and the majority of our consultants are involved in research programmes there. Many of our patients are offered the opportunity to get involved in national or locally run clinical trials providing access to the latest treatments. Find out more about joining clinical trials here.

Our CLL services are based at the University College Hospital Macmillan Cancer Centre and include outpatient based chemotherapy and a full range of supportive care including complementary therapies. Patients requiring more intensive treatment may be cared for on the Ambulatory Care Unit or in University College Hospital (UCH).


Prof Amit Nathwani, Professor of Haematology and Consultant Haematologist

Dr Amit Nathwani

Professor Amit Nathwani specialises in treating haematological cancer including chronic lymphocytic leukaemia.

"My primary research interest is to use gene transfer technology to develop novel therapies for NHS priority areas such as cancer and chronic disorders. We hope to develop a novel immunotherapy approach for CLL."

Full consultant profile

 Clinical Nurse Specialists (CNS)

Barbara von Barsewisch, Macmillan Lymphoma Clinical Nurse Specialist

Barbara von Barsewisch

Barbara specialises in lymphoma and chronic lymphocytic leukaemia (CLL), as well as HIV-related lymphomas Kaposi’s sarcoma and Castleman’s disease. Her main research interests focus on examining ways in which patients can receive a better service. These have included working on outpatient surveys and the creation of a rapid access clinic. Barbara is also on the guideline committee of the National Institute for Health and Care Excellent guidelines update “Haematological Cancers: Improving Outcomes”.

“The most rewarding part of my role at UCLH is being able to be there for patients and their families from the time of diagnosis through treatment and beyond. I take pride in supporting, educating and sharing with patients along the cancer journey, knowing that my input can help allay fears. I ensure a smooth pathway within UCLH and the community and act as a safety net for patients undergoing treatment between appointments and follow up.